RVMD Competitors & Alternatives
Compare Revolution Medicines Inc with similar stocks in the same industry
Biotechnology
RVMD
Main Stock$180.70
Tradestie Score
53
Market Cap
$8.57B
Revenue Growth
-1.0%
Analyst Upside
+52.1%
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
REGN
Regeneron Pharmaceuticals Inc
|
$959.41
|
$63.59B | 20.2 | 35 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$159.85
|
$60.38B | 7.7 | 55 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$977.58
|
$46.96B | 33.7 | 35 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$419.98
|
$36.81B | 54.4 | 35 | Compare |
|
INSM
Insmed, Inc.
|
$120.75
|
$31.13B | - | 37 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$87.65
|
$24.57B | - | 62 | Compare |
|
GMAB
Genmab A/S ADS
|
$53.87
|
$19.56B | 46.2 | 33 | Compare |
|
INCY
Incyte Genomics Inc
|
$122.27
|
$16.93B | 61.4 | 52 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$70.01
|
$15.70B | 45.4 | 36 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$16.64
|
$15.22B | - | 42 | Compare |
More RVMD Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
215 stocks in this industry